Tanım

The global emerging medical device technologies market is poised to grow by US$ 103.6 sırasında milyar 2022-2028, CAGR'da ilerliyor 12.3% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for emerging medical device technologies. The global emerging medical device technologies market is segmented on the basis of segment, ve bölge. By segment, the global emerging medical device technologies market has been segmented into cardiovascular, diabetes, drug delivery, gastrointestinal endoscopy, IVD (vitro diagnostic), neurology, ophthal, orthopedic, wound care. İçinde 2021, the cardiovascular segment made up the largest share of revenue generated by the emerging medical device technologies market. coğrafi olarak, the global emerging medical device technologies market is segmented into Asia Pacific, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW). North America was the largest contributor to the global emerging medical device technologies market in 2021.

The cardiovascular devices market is further segmented into electrophysiology (EP), endovascular aortic repair (EVAR), heart failure devices, interventional cardiology (IC), peripheral vascular devices (PVD), subcutaneous ICD, and transcatheter heart valve therapy. Bunların arasında, the heart failure devices segment was accounted for the highest revenue generator in 2021. Üstelik, the IVD devices market has been categorized into advanced cancer molecular diagnostics, companion diagnostics, and professional POC. The professional POC segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. The orthopedic devices market is further divided into extremity joint reconstruction, and soft tissue fixation and repair. According to the research, the soft tissue fixation and repair segment had the largest share in the global emerging medical device technologies market.

The global emerging medical device technologies market is highly competitive. The prominent players operating in the global emerging medical device technologies market include 3M Company, Abbott Laboratories, Agilent Technologies Inc., Allergan Inc., Biolase Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina Inc., Karl Storz SE & ortak. KİLOGRAM, Medtronic plc, Mindray Medical International Limited, Myriad Genetics Inc., Nidek Co. Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers AG, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings Inc. Competitive landscape gives a description of the competitive nature of the global emerging medical device technologies market and a description of the leading companies. Son yıllarda piyasayı şekillendiren önemli finansal anlaşmalar belirlendi.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the emerging medical device technologies market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Segment: cardiovascular, diabetes, drug delivery, gastrointestinal endoscopy, IVD (vitro diagnostic), neurology, ophthal, orthopedic, wound care
Bölge: Asya Pasifik, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028
Adı geçen şirket: 3M Company, Abbott Laboratories, Agilent Technologies Inc., Allergan Inc., Biolase Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina Inc., Karl Storz SE & ortak. KİLOGRAM, Medtronic plc, Mindray Medical International Limited, Myriad Genetics Inc., Nidek Co. Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers AG, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings Inc.

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global emerging medical device technologies market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Emerging medical device technologies market overview
Parça 3. Market breakdown by segment
– Cardiovascular
– Diabetes
– Drug delivery
– Gastrointestinal endoscopy
– IVD (vitro diagnostic)
– Neurology
– Ophthal
– Orthopedic
– Wound care
Parça 4. Market breakdown by region
– Asya Pasifik
– Avrupa
– Kuzey Amerika
– Dünyanın Geri Kalanı (RoW)
Parça 5. Anahtar şirketler
– 3M Company
– Abbott Laboratories
– Agilent Technologies, A.Ş..
– Allergan Inc.
– Biolase, A.Ş..
– BioMerieux S.A.
– Boston Scientific Corp.
– Cardinal Health, A.Ş..
– Cook Group
– Cordis Corporation
– Edwards Lifesciences Corporation
– GE Healthcare
– Illumina, A.Ş..
– Karl Storz SE & ortak. KİLOGRAM
– Medtronic plc
– Mindray Medical International Limited
– Myriad Genetics, A.Ş..
– Nidek Co., Ltd..
– Novartis International AG
– Roche Holding AG
– Shimadzu Corp.
– Siemens Healthineers AG
– Smith & Nephew plc
– Stryker Corporation
– Terumo Corp.
– Zimmer Biomet Holdings, A.Ş..
StratejiHelix Hakkında
Sorumluluk reddi beyanı